According to the prolactinoma guidelines of the Endocrine Society, the diagnosis was based on clinical signs of hyperprolactinaemia, elevated levels of prolactin and a pituitary tumour on MRI (Melmed et al. 2011). The gene discussed is PRL; the disease is hyperprolactinemia.